StockNews.AI
USNA
StockNews.AI
119 days

USANA Health Sciences Reports First Quarter 2025 Results and Reiterates Full-Year Outlook

1. USANA's Q1 2025 net sales increased by 10% to $250 million. 2. Net earnings fell to $9.4 million; EPS decreased compared to Q1 2024.

2m saved
Insight
Article

FAQ

Why Bearish?

Despite revenue growth, reduced net earnings and EPS may concern investors and lead to stock declines, similar to past patterns where profit decreases overshadowed sales growth. Historical trends show that earnings misses can lead to sell-offs.

How important is it?

The article contains critical financial data that directly impacts USNA's stock valuation. The decline in earnings can significantly affect investor sentiment and market performance.

Why Short Term?

Immediate market reactions can follow quarterly earnings reports, especially if they underperform expectations. Short-term reactions often manifest quickly as investors digest new financial data.

Related Companies

AVXLNKETCAGDOV
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended March 29, 2025. Key Financial Results First Quarter 2025 vs. First Quarter 2024 Net sales of $250 million versus $228 million, representing year-over-year growth of 10% and 12% in constant currency. Net earnings of $9.4 million versus $16.5 million. Diluted EPS of $0.49 as compared with $0.86. Adjusted diluted EPS(1) of $0.73 as compared with $0.86. Adju.

Related News